CEBP  Translational Cancer Medicine 2008: Cancer Clinical Trials and Personalized Medicine
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lampe, J. W.
Right arrow Articles by Slavin, J. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lampe, J. W.
Right arrow Articles by Slavin, J. L.
Cancer Epidemiology Biomarkers & Prevention Vol. 8, 699-707, August 1999
© 1999 American Association for Cancer Research

Urinary Isoflavonoid and Lignan Excretion on a Western Diet: Relation to Soy, Vegetable, and Fruit Intake1

Johanna W. Lampe2, Deborah R. Gustafson3, Andrea M. Hutchins, Margaret C. Martini4, Sue Li, Kristiina Wähälä, Greg A. Grandits, John D. Potter and Joanne L. Slavin

Cancer Prevention Research Program, Fred Hutchinson Cancer Research Center, Seattle, Washington 98109 [J. W. L., S. L., J. D. P.]; Department of Food Science and Nutrition, University of Minnesota, St. Paul, Minnesota 55108 [D. R. G., A. M. H., M. C. M., J. L. S.]; Department of Organic Chemistry, University of Helsinki, Helsinki, Finland [K. W.]; and Coordinating Centers for Biometric Research, University of Minnesota, Minneapolis, Minneapolis 55414 [G. A. G.]

Dietary isoflavone and lignan phytoestrogens are potential chemopreventive agents. This has led to a need to monitor exposure to these compounds in human populations and to determine which components of a mixed diet contribute to the exposure. Typically, urinary isoflavonoid excretion is associated with soy consumption and that of lignans is associated with whole grains. However, other plant foods are known to contain phytoestrogen precursors. The purpose of this study was to examine the association between urinary isoflavonoid and lignan excretion and intakes of vegetables and fruits (V&F). Isoflavonoids (genistein, daidzein, O-desmethylangolensin, and equol) and lignans (enterolactone, enterodiol, and matairesinol) were measured in urine collected for 3 days from 49 male and 49 female volunteers (age, 18–37 years) reporting a wide range of habitual V&F intakes. Dietary intakes were assessed using 5-day diet records and a food frequency questionnaire. V&F groupings (total V&F, total V, total F, soyfoods, and V&F grouped by botanical families) were used to assess the relationship between V&F intake and urinary isoflavonoid and lignan excretion. Pearson correlations were performed. Intake of soyfoods was correlated significantly with urinary genistein (r = 0.40; P = 0.0001), O-desmethylangolensin (r = 0.37; P = 0.0002), daidzein (r = 0.34; P = 0.0007), and the sum of isoflavonoids (r = 0.39; P = 0.0001). There was no association between equol excretion and soy intake or between the isoflavonoids and any other V&F groupings. In addition, isoflavonoid excretion was correlated positively with intake of high-fat and processed meats, particularly among men who did not consume soy. This suggests that, even in the United States, on a Western diet, soyfoods are the primary contributors to isoflavone intake; however, additional "hidden sources" of soy may also contribute to exposure. In contrast, a variety of fiber-containing foods contributed to lignan excretion; the sum of the urinary lignans, enterodiol, enterolactone, and matairesinol, was associated with intake of total F (r = 0.27; P = 0.008), total V&F (r = 0.25; P = 0.01), soyfoods (r = 0.28; P = 0.006), and dietary fiber (r = 0.36; P = 0.0003). Overall, urinary phytoestrogens (isoflavonoids + lignans) were significantly higher in "high" compared with "low" V&F consumers. Compared with the "low" V&F group, the "high" group consumed diets that were, on average, higher in fiber and carbohydrate and soyfoods and lower in fat; thus, the urinary phytoestrogens may also be a useful marker of healthier dietary patterns.




This article has been cited by other articles:


Home page
Am. J. Clin. Nutr.Home page
C. Atkinson, K. M Newton, E. J A. Bowles, M. Yong, and J. W Lampe
Demographic, anthropometric, and lifestyle factors and dietary intakes in relation to daidzein-metabolizing phenotypes among premenopausal women in the United States
Am. J. Clinical Nutrition, March 1, 2008; 87(3): 679 - 687.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
S.-A. Lee, W. Wen, Y.-B. Xiang, S. Barnes, D. Liu, Q. Cai, W. Zheng, and X. O. Shu
Assessment of Dietary Isoflavone Intake among Middle-Aged Chinese Men
J. Nutr., April 1, 2007; 137(4): 1011 - 1016.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Coll. Nutr.Home page
M. R. French, L. U. Thompson, and G. A. Hawker
Validation of a Phytoestrogen Food Frequency Questionnaire with Urinary Concentrations of Isoflavones and Lignan Metabolites in Premenopausal Women
J. Am. Coll. Nutr., February 1, 2007; 26(1): 76 - 82.
[Abstract] [Full Text] [PDF]


Home page
J Clin PharmacolHome page
M. Nakajima, M. Itoh, H. Yamanaka, T. Fukami, S. Tokudome, Y. Yamamoto, H. Yamamoto, and T. Yokoi
Isoflavones Inhibit Nicotine C-Oxidation Catalyzed by Human CYP2A6.
J. Clin. Pharmacol., March 1, 2006; 46(3): 337 - 344.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
I. E. J. Milder, E. J. M. Feskens, I. C. W. Arts, H. B. B. de Mesquita, P. C. H. Hollman, and D. Kromhout
Intake of the Plant Lignans Secoisolariciresinol, Matairesinol, Lariciresinol, and Pinoresinol in Dutch Men and Women
J. Nutr., May 1, 2005; 135(5): 1202 - 1207.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
L. M. Butler, W.-P. Koh, H.-P. Lee, M. C. Yu, and S. J. London
Dietary Fiber and Reduced Cough with Phlegm: A Cohort Study in Singapore
Am. J. Respir. Crit. Care Med., August 1, 2004; 170(3): 279 - 287.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
J. A. Nettleton, K. A. Greany, W. Thomas, K. E. Wangen, H. Adlercreutz, and M. S. Kurzer
Plasma Phytoestrogens Are Not Altered by Probiotic Consumption in Postmenopausal Women with and without a History of Breast Cancer
J. Nutr., August 1, 2004; 134(8): 1998 - 2003.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
S. Kreijkamp-Kaspers, L. Kok, D. E. Grobbee, E. H. F. de Haan, A. Aleman, J. W. Lampe, and Y. T. van der Schouw
Effect of Soy Protein Containing Isoflavones on Cognitive Function, Bone Mineral Density, and Plasma Lipids in Postmenopausal Women: A Randomized Controlled Trial
JAMA, July 7, 2004; 292(1): 65 - 74.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
P. B. Grace, J. I. Taylor, Y.-L. Low, R. N. Luben, A. A. Mulligan, N. P. Botting, M. Dowsett, A. A. Welch, K.-T. Khaw, N. J. Wareham, et al.
Phytoestrogen Concentrations in Serum and Spot Urine as Biomarkers for Dietary Phytoestrogen Intake and Their Relation to Breast Cancer Risk in European Prospective Investigation of Cancer and Nutrition-Norfolk
Cancer Epidemiol. Biomarkers Prev., May 1, 2004; 13(5): 698 - 708.
[Abstract] [Full Text] [PDF]


Home page
Obstet GynecolHome page
J. Maubach, H. T. Depypere, J. Goeman, J. Van Der Eycken, A. Heyerick, M. E. Bracke, P. Blondeel, and D. De Keukeleire
Distribution of Soy-Derived Phytoestrogens in Human Breast Tissue and Biological Fluids
Obstet. Gynecol., May 1, 2004; 103(5): 892 - 898.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
L. Keinan-Boker, Y. T van Der Schouw, D. E Grobbee, and P. H. Peeters
Dietary phytoestrogens and breast cancer risk
Am. J. Clinical Nutrition, February 1, 2004; 79(2): 282 - 288.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
A. N. Begum, C. Nicolle, I. Mila, C. Lapierre, K. Nagano, K. Fukushima, S.-M. Heinonen, H. Adlercreutz, C. Remesy, and A. Scalbert
Dietary Lignins Are Precursors of Mammalian Lignans in Rats
J. Nutr., January 1, 2004; 134(1): 120 - 127.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
J. W. Lampe
Isoflavonoid and Lignan Phytoestrogens as Dietary Biomarkers
J. Nutr., March 1, 2003; 133(3): 956S - 964.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
K. Stumpf and H. Adlercreutz
Short-Term Variations in Enterolactone in Serum, 24-Hour Urine, and Spot Urine and Relationship with Enterolactone Concentrations
Clin. Chem., January 1, 2003; 49(1): 178 - 181.
[Full Text] [PDF]


Home page
J. Nutr.Home page
L. K. Boker, Y. T. Van der Schouw, M. J. J. De Kleijn, P. F. Jacques, D. E. Grobbee, and P. H. M. Peeters
Intake of Dietary Phytoestrogens by Dutch Women
J. Nutr., June 1, 2002; 132(6): 1319 - 1328.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
C. Atkinson, H. E. Skor, E. D. Fitzgibbons, D. Scholes, C. Chen, K. Wahala, S. M. Schwartz, and J. W. Lampe
Overnight Urinary Isoflavone Excretion in a Population of Women Living in the United States, and Its Relationship to Isoflavone Intake
Cancer Epidemiol. Biomarkers Prev., March 1, 2002; 11(3): 253 - 260.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
N. K. Horner, A. R. Kristal, J. Prunty, H. E. Skor, J. D. Potter, and J. W. Lampe
Dietary Determinants of Plasma Enterolactone
Cancer Epidemiol. Biomarkers Prev., January 1, 2002; 11(1): 121 - 126.
[Abstract] [Full Text]


Home page
Am. J. Clin. Nutr.Home page
A. Kilkkinen, K. Stumpf, P. Pietinen, L. M Valsta, H. Tapanainen, and H. Adlercreutz
Determinants of serum enterolactone concentration
Am. J. Clinical Nutrition, June 1, 2001; 73(6): 1094 - 1100.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
P. Pietinen, K. Stumpf, S. Männistö, V. Kataja, M. Uusitupa, and H. Adlercreutz
Serum Enterolactone and Risk of Breast Cancer: A Case-Control Study in Eastern Finland
Cancer Epidemiol. Biomarkers Prev., April 1, 2001; 10(4): 339 - 344.
[Abstract] [Full Text]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
I. d. Tonkelaar, L. Keinan-Boker, P. Van’t Veer, C. J. M. Arts, H. Adlercreutz, J. H. H. Thijssen, and P. H. M. Peeters
Urinary Phytoestrogens and Postmenopausal Breast Cancer Risk
Cancer Epidemiol. Biomarkers Prev., March 1, 2001; 10(3): 223 - 228.
[Abstract] [Full Text]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
K. Stumpf, P. Pietinen, P. Puska, and H. Adlercreutz
Changes in Serum Enterolactone, Genistein, and Daidzein in a Dietary Intervention Study in Finland
Cancer Epidemiol. Biomarkers Prev., December 1, 2000; 9(12): 1369 - 1372.
[Abstract] [Full Text]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
A. M. Hutchins, M. C. Martini, B. A. Olson, W. Thomas, and J. L. Slavin
Flaxseed Influences Urinary Lignan Excretion in a Dose-dependent Manner in Postmenopausal Women
Cancer Epidemiol. Biomarkers Prev., October 1, 2000; 9(10): 1113 - 1118.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation
Copyright © 1999 by the American Association for Cancer Research.